Mkts

Health Catalyst, Inc

NASDAQ: HCAT
$1.58-0.11 (-6.51%)
As of Nov 2, 4:00 PM ET

Key statistics

Day range
1.581.77
52-week range
0.953.37
Today
Open1.72
Previous close1.58
Volume—
Valuation
Market cap121.54M
P/E ratio—
EPS (TTM)-3.68
Income & risk
Dividend / yield—
Beta1.51
Avg volume749.8K
Discussion

HCAT News

Stories mentioning HCAT from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue70,75674,67976,32380,72179,41379,60676,35375,902
Cost of Goods Sold
Gross Profit40,13336,289
Operating Expenses
Research & Development9,7799,91112,28112,39215,18615,00214,19313,884
Sales General & Admin
Total Operating Expenses141,940125,46355,32575,33556,40652,19147,72751,649
Operating Income (Loss)(106,477)(86,080)(17,509)(37,094)(20,171)(17,500)(13,687)(15,807)
Interest Income
Interest Expense
Other Expense
Pretax Income
Tax Provision414.00379.0041.0081.00215.00625.00(475.00)70.00
Net Income (Loss)(111,026)(91,025)(22,229)(40,978)(23,742)(20,673)(14,726)(13,516)
Earnings Per Share (Basic)(1.53)(1.30)(0.32)(0.59)(0.35)(0.34)(0.24)(0.23)
Earnings Per Share (Diluted)(1.53)(1.30)(0.32)(0.59)(0.35)(0.34)(0.24)(0.23)
Weighted Average Shares Outstanding (Basic)72,59369,89670,37769,62668,55260,18560,44159,304
Weighted Average Shares Outstanding (Diluted)72,59369,89670,37769,62668,55260,18560,44159,304

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About HCAT

Health Catalyst, Inc (NASDAQ: HCAT) is a stock listed on the Nasdaq Stock Market under the ticker symbol HCAT. It last traded at $1.58 (Nov 2, 2026, 4:00 PM ET), down 6.5% on the day. That gives Health Catalyst a market capitalisation of $121.5M.

Over the past 52 weeks HCAT has traded between $0.9500 and $3.37.

Revenue for the quarter ended Mar 31, 2026 was $70.8M; a net loss of $111.0M. Revenue was down 10.9% from $79.4M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$70.8M-$111.0M-156.9%
Dec 31, 2025$74.7M-$91.0M-121.9%
Sep 30, 2025$76.3M-$22.2M-29.1%
Jun 30, 2025$80.7M-$41.0M-50.8%

From Health Catalyst’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…